Status:

COMPLETED

IQP-PO-101 for the Regulation of Bowel Movement Frequency

Lead Sponsor:

InQpharm Group

Conditions:

Constipation

Irregular Bowel Movement Frequency

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

The purpose of the study is to evaluate the safety and efficacy of IQP-PO-101 in regulating the bowel movement frequency

Eligibility Criteria

Inclusion

  • A subject must have experienced 2 - 4 bowel movements per week and at least 2 of the following symptoms over the preceding 3 months (self-reported):
  • Excessive straining
  • Lumpy or hard stools
  • Sensation of anorectal obstruc-tion
  • A sense of incomplete evacua-tion of bowel movements
  • A need for digital manipulation to facilitate evacuation
  • Recorded between 4 and 9 defecations in the 14-day bowel movement diary during the run-in period
  • Subjects of childbearing potential must agree to use appropriate contraceptive methods during run-in and treatment period
  • Commitment to avoid the use of any laxatives and/ or other medicinal products/ supplements that may interfere with bowel movement frequency during the run-in and treatment period
  • Written informed consent.

Exclusion

  • Known sensitivity to the ingredients of the device
  • Any organic gastrointestinal diseases, congenital or otherwise
  • Presence of occult blood on screening
  • Constipation that may have been drug-induced
  • Use of any laxative/ products that help ease bowel movements within 7 days of the screening visit
  • Constipation other than idiopathic constipation
  • Presence of other factor(s) that, in the in-vestigator's judgement, should preclude subject participation

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2013

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01809587

Start Date

March 1 2013

End Date

August 1 2013

Last Update

January 14 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Analyze & Realize Ag

Berlin, State of Berlin, Germany, 10369